Jonas Samuel Jutzi (Jonas S Jutzi)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Transforming Growth Factor

Epithelial Mesenchymal Transition

Endoplasmic Reticulum

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Anne Marie Staehle, Jan Caspar Peeken, Georg Vladimirov, Mirjam Elisabeth Hoeness, Sarolta Bojtine Kovacs, Nikolaos Karantzelis, Albert Gruender, Christoph Koellerer, Jonas Samuel Jutzi, Heike Luise Pahl, Hans Felix Staehle
The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2 V617F mutated cells. Leukemia (2023)
Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Jonas Samuel Jutzi, Ann Mullally
Two to tango! IL-13 and TGF-β drive myelofibrosis. Blood 140 (26) (2023)
Jonas Samuel Jutzi, Anna E Marneth, Michele Ciboddo, Angel Guerra-Moreno, María José Jiménez-Santos, Anastasia Kosmidou, James W Dressman, Hongyan Liang, Rebecca Hamel, Patricia Lozano, Elisa Rumi, John G Doench, Jason Gotlib, Anandi Krishnan, Shannon Elf, Fátima Al-Shahrour, Ann Mullally
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs. Blood 140 (11) (2022)
Jonas Samuel Jutzi, Anna E Marneth, María José Jiménez-Santos, Jessica Hem, Angel Guerra-Moreno, Benjamin Rolles, Shruti Bhatt, Samuel A Myers, Steven A Carr, Yuning Hong, Olga Pozdnyakova, Peter van Galen, Fátima Al-Shahrour, Anna S Nam, Ann Mullally
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response. Leukemia (2022)
Hans Felix Staehle, Heike Luise Pahl, Jonas Samuel Jutzi
The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies. Biomolecules 11 (12) (2021)
Hans F Staehle, Johannes Heinemann, Albert Gruender, Anne M Omlor, Heike Luise Pahl, Jonas Samuel Jutzi
Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice. PloS one 15 (2) (2020)
Jonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, Sandra Kaiser, Doris Steinemann, Mathijs Arnoud Sanders, Adil S A Hinai, Annelieke Zeilemaker, Sarolta Bojtine Kovacs, Christoph Koellerer, Jenny Ostendorp, Konrad Aumann, Wei Wang, Emmanuel Raffoux, Bruno Cassinat, Lars Bullinger, Brigitte Schlegelberger, Peter J M Valk, Heike Luise Pahl
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood 133 (16) (2019)
Alessandro Prestipino, Alica J Emhardt, Konrad Aumann, David O'Sullivan, Sivahari P Gorantla, Sandra Duquesne, Wolfgang Melchinger, Lukas M Braun, Slavica Vuckovic, Melanie Boerries, Hauke Busch, Sebastian Halbach, Sandra Pennisi, Teresa Poggio, Petya Apostolova, Pia Veratti, Michael Hettich, Gabriele Niedermann, Mark D Bartholomä, Khalid Shoumariyeh, Jonas Samuel Jutzi, Julius Wehrle, Christine Dierks, Heiko Becker, Annette Schmitt-Graeff, Marie Follo, Dietmar Pfeifer, Jan C Rohr, Sebastian Fuchs, Stephan Ehl, Frederike A Hartl, Susana Minguet, Christoph Cornelius Miething, Florian H Heidel, Nicolaus M Kröger, Ioanna Triviai, Tilman Brummer, Jürgen Finke, Anna L Illert, Eliana Ruggiero, Chiara Bonini, Justus Duyster, Heike Luise Pahl, Steven W Lane, Geoffrey R Hill, Bruce R Blazar, Nikolas von Bubnoff, Erika L Pearce, Robert Zeiser
Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Science translational medicine 10 (429) (2019)
Jan C Peeken, Jonas Samuel Jutzi, Julius Wehrle, Christoph Koellerer, Hans F Staehle, Heiko Becker, Elias Schoenwandt, Thalia S Seeger, Daniel H Schanne, Monika Gothwal, Christopher J Ott, Albert Gründer, Heike Luise Pahl
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms. Blood 131 (18) (2018)